Jeffrey B. Mirviss - Jan 4, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP&Pres, Periph Intervent
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
Jan 4, 2023
Transactions value $
-$313,123
Form type
4
Date filed
1/4/2023, 03:21 PM
Previous filing
Jan 3, 2023
Next filing
Feb 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale -$313K -6.75K -7.09% $46.38 88.5K Jan 4, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2 Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.18 to $46.54, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.